Search
Now showing items 1-10 of 21
Article
WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2
| Date Issued:
2021 | Copyright:
open access
Preprint
Unlike Chloroquine, mefloquine inhibits SARS-CoV-2 infection in physiologically relevant cells and does not induce viral variants
| Date Issued:
2021 | Copyright:
open access
Article
Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells
| Date Issued:
2022 | Copyright:
open access
Article
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones
| Date Issued:
2022 | Copyright:
open access
Preprint
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
| Date Issued:
2022 | Copyright:
open access
Preprint
Non-permissive SARS-CoV-2 infection in human neurospheres (preprint)
| Date Issued:
2021 | Copyright:
open access
Preprint
Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
| Date Issued:
2020 | Copyright:
open access
Article
Combination of antiviral drugs inhibits SARS-CoV- 2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture
| Date Issued:
2022 | Copyright:
open access
Article
SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites
| Date Issued:
2021 | Copyright:
open access
Article
VIP plasma levels associate with survival in severe COVID-19 patients, correlatingwith protective effects in SARS-CoV-2-infected cells
| Date Issued:
2022 | Copyright:
open access